In pediatric advanced life support (PALS), for a 4‑year‑old child who is pulseless and apneic with high‑quality cardiopulmonary resuscitation (CPR) and established vascular access, what is the next intervention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Administer Epinephrine 0.01 mg/kg IV/IO Immediately

For a pulseless and apneic 4-year-old with established vascular access and ongoing high-quality CPR, your next intervention is to administer epinephrine 0.01 mg/kg (0.1 mL/kg of the 0.1 mg/mL concentration) IV or IO, with a maximum dose of 1 mg. 1

Critical Dosing Correction

The dose listed in your question (0.1 mg/kg) is incorrect and represents a 10-fold overdose that could be fatal. The correct PALS dose is 0.01 mg/kg (not 0.1 mg/kg). This translates to 0.1 mL/kg of the 1:10,000 (0.1 mg/mL) concentration. 1

Why Epinephrine is the Priority

The 2025 AHA/AAP guidelines emphasize that for initial nonshockable rhythms (asystole or pulseless electrical activity), administering epinephrine as soon as possible is associated with favorable outcomes for infants and children in cardiac arrest. 2 Since you have established vascular access, there should be no delay in drug administration.

The algorithm is straightforward:

  • High-quality CPR is ongoing (confirmed in your scenario)
  • Vascular access is established (confirmed in your scenario)
  • Next step: Epinephrine immediately, then repeat every 3-5 minutes 1, 2

Why the Other Options Are Wrong

Sellick Maneuver (Cricoid Pressure)

This is not a priority intervention in cardiac arrest and does not appear in the PALS drug therapy or CPR quality algorithms. It has no role in improving outcomes during pulseless arrest.

Atropine 2 mg/kg

Atropine is not indicated in pediatric cardiac arrest. The dose of 2 mg/kg would also be dangerously excessive and potentially lethal. Atropine has been removed from pediatric cardiac arrest algorithms and is not recommended for pulseless arrest. 1

Transcutaneous Pacing

Pacing is not indicated for pulseless cardiac arrest. It may have a role in symptomatic bradycardia with a pulse, but in a pulseless patient, the priority is CPR and epinephrine, not pacing.

Proper PALS Sequence

  1. Continue high-quality CPR (15:2 compression-ventilation ratio with 2 rescuers, or continuous compressions if advanced airway in place)
  2. Administer epinephrine 0.01 mg/kg IV/IO as soon as vascular access is available
  3. Repeat epinephrine every 3-5 minutes throughout the resuscitation 1, 2
  4. Identify and treat reversible causes (H's and T's)
  5. Consider advanced airway if not already placed
  6. Monitor CPR quality with physiologic feedback if available (diastolic BP ≥25 mm Hg in infants, ≥30 mm Hg in children ≥1 year) 2

Common Pitfalls to Avoid

  • Dosing errors: The 10-fold epinephrine dosing error (0.1 mg/kg instead of 0.01 mg/kg) is one of the most dangerous medication errors in pediatrics. Always double-check the concentration and volume.
  • Delayed epinephrine: Do not wait to administer epinephrine once vascular access is established. Early epinephrine in nonshockable rhythms improves outcomes. 2, 3
  • Wrong medication: Atropine has no role in pediatric pulseless arrest and should not be administered.
  • Interrupting CPR: Minimize interruptions in chest compressions while administering medications. 1

Related Questions

What are the possible differential diagnoses for a 13-year-old with a persistent sensation of water in the ear without pain or signs of infection?
What is the appropriate management for ear wax (cerumen) in a 14‑month‑old child?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What is the recommended management for a 13-year-old female cross-country runner with shooting pain in the right hip and upper buttock during weight-bearing?
In a 24-year-old male with a maculopapular erythematous rash that is painful and pruritic over the entire body, preceded by fever one day earlier, what is the most likely diagnosis and recommended treatment?
According to the latest American Heart Association guidelines, what is the recommended duration of targeted temperature management after return of spontaneous circulation following cardiac arrest?
Are polypoid lesions on the lateral bladder wall likely malignant or benign?
During CPR on a patient rescued from a pool after a diving injury who may have a cervical spine injury and is receiving bag‑mask ventilation, should I provide inline cervical immobilization and open the airway with a jaw‑thrust maneuver instead of a head‑tilt‑chin‑lift?
What is the appropriate capecitabine dose (mg/m²) for concurrent chemoradiation in rectal cancer—should it be 825 mg/m² twice daily or reduced to 625 mg/m² in the setting of impaired renal function?
Does the LUCAS mechanical chest compression device generate a cardiac rhythm or restore spontaneous circulation?
How should a patient on metformin with vitamin B12 deficiency be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.